IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q4 2021 Holdings

Filed 2022-02-14 | 7 holdings | $399.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines, Inc.(RVMD)COM76155X100$139.0K5,524,03134.8%
Pliant Therapeutics, Inc.(PLRX)COM729139105$78.8K5,839,16019.7%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$70.1K2,422,54917.6%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$70.1K3,962,20217.5%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$17.3K6,391,1764.3%
Decibel Therapeutics, Inc.COM24343R106$14.6K3,139,6853.7%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$9.6K1,148,7802.4%